Showing results (31-40 of 338) with videos related to
Sort By:
Pageof 34
American Journal of Hospital Pharmacy|April 1, 1978
Drug therapy reviews: clinical use of hemostatic agentsG D Lowe, D H LawsonAtherosclerosis|December 23, 1998
Effects of lipids and lipoproteins on thrombosis and rheologyR S Rosenson, G D LoweBMJ (Clinical Research Ed.)|January 6, 1996
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillationG Y Lip, G D LoweBritish Journal of Clinical Pharmacology|May 1, 1996
Warfarin and aspirin as thromboprophylaxis in atrial fibrillationG Y Lip, G D LoweThe British Journal of Surgery|August 1, 1997
Fibrinogen, fibrin turnover, endothelial products and vascular surgeryK R Woodburn, G D LoweBlood|October 15, 1992
Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA)J Koopman, F Haverkate, J Grimbergen, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT FoundationP Meijer, C Kluft, F Haverkate, et al.Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|May 1, 1979
A novel method for the rapid purification of human and rat fibrin(ogen) degradation products in high yieldsI A van Ruijven-Vermeer, W Nieuwenhuizen, F Haverkate, et al.Thrombosis and Haemostasis|February 12, 1991
The impact of sequential quality assessment exercises on laboratory performance: the multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT)S G Thompson, G Calori, J M Thomson, et al.The Journal of Clinical Investigation|July 1, 1992
Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----ThrJ Koopman, F Haverkate, S T Lord, et al.Pageof 34